Annette M Langer-Gould

22PUBLICATIONS
23CO-AUTHORS
Disease surveillanceApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Medical infection agents (incl. prions)Haematological tumoursRegenerative medicine (incl. stem cells)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (22)

|Jul 15, 2026
Anti-NMDA receptor encephalitis outcomes in a population-based cohort.

|Apr 09, 2026
Comparative Effectiveness of Rituximab Dosed Every 6 and 12 Months in Relapsing Multiple Sclerosis.

Annette Langer-Gould, Bonnie H Li, Jessica B Smith

|Mar 19, 2026
De-escalating low-dose rituximab up to every 24-month infusions and the risk of disease activity in people with relapsing multiple sclerosis who were stable the first year on therapy.

Annette M Langer-Gould, Jessica B Smith, Allen Scott Nielsen

|Dec 30, 2025
Letter Concerning Comparative Safety Profiles of Ocrelizumab and Rituximab in MS Treatment.

Anders Svenningsson, Fredrik Piehl, Annette M Langer-Gould

|Dec 22, 2025
Comparative Effectiveness of Rituximab Dosed Every 6 and 12 Months in Relapsing Multiple Sclerosis.

Annette Langer-Gould, Bonnie H Li, Jessica B Smith

|May 27, 2025
Embodiment of structural racism and multiple sclerosis risk and outcomes in the USA.

Annette M Langer-Gould, Tara J Cepon-Robins, Jada Benn Torres

Pageof 4

Frequent Collaborators

6 joint publications

Jessica B Smith

5 joint publications

Bonnie H Li

3 joint publications

Simon Englund

3 joint publications

Stanley Xu